My Treatment Approach: Optimizing Treatment for Chronic GVHD

This educational program, led by experts Shernan Holtan, MD, and Haris Ali, MD, explores the latest strategies and emerging treatments for optimizing management of chronic graft-vs-host disease (cGVHD), including monitoring techniques, therapeutic options, and patient-reported outcomes.

EP. 1: Differentiating Acute and Chronic Graft-vs-Host Disease

August 29th 2024

After a brief introduction, Shernan Holtan, MD, and Haris Ali, MD, discuss the distinction between acute and chronic graft-vs-host disease.

EP. 2: Navigating Chronic GVHD: Phases of Pathophysiology and Best Practices in Patient Monitoring

August 29th 2024

Medical experts discuss navigating chronic GVHD.

EP. 3: Optimizing Chronic GVHD Therapy

September 5th 2024

Medical experts discuss overall goals for cGVHD treatment as well as concerns with long-term corticosteroid use in treatment.

EP. 4: Navigating Treatment Decisions in Chronic GVHD

September 5th 2024

Medical experts discuss criteria for switching GVHD treatments and how to choose between available treatment options.

EP. 5: Overview of Advanced Therapies in cGVHD

September 12th 2024

Medical experts discuss advanced therapies in cGVHD.

EP. 6: Overview of the ROCKstar Study

September 12th 2024

Medical experts discuss the data that led to belumosudil’s FDA approval.

EP. 7: Considerations for Third-Line Treatment in Chronic GVHD

September 19th 2024

Medical experts discuss considerations for third-line treatment in chronic GVHD.

EP. 8: Clinical Scenario: Treatment Selection in the third line and beyond in cGVHD

September 19th 2024

Medical experts discuss treatment selection for a specific clinical scenario.

EP. 9: Recent Updates: REACH3, ROCKstar, and RWD

September 26th 2024

Medical experts discuss the recent updates presented at ASH 2023 and TANDEM 2024.

EP. 10: AGAVE-201: Axatilimab for cGVHD

September 26th 2024

Medical experts discuss the mechanism of action within axatilimab.